Artificial Heart and 'Optical Detective' Featured at WILL Summit as Companies File IPO Prospectuses

Special Session of the Legend Star WILL Conference

Xiangyihui 2 MED TED

Only Technology Can Create Disruption

Event Registration Link:http://m.grouplus.cn/ebsufm

Scan the QR Code to Enter Future Healthcare

On the evening of July 9, 2016, Legend Star joined hands with VCBeat to jointly organizeThe 2nd Session of Xiangyihui MED TED Keynote Speech EventThe event will be held at the Crowne Plaza Beijing New Yunnan. As a special segment of the Legend Star WILL Conference, the event invited six tech luminaries to deliver presentations and demonstrations on six distinct cutting-edge medical technologies, paying deep tribute to “Future Healthcare”!

He holds a bachelor’s degree in Physics from Peking University and a master’s degree in Biophysics from the University of California, San Diego. Recognized as one of the “Top Ten Returning Overseas Chinese Stars in Zhongguancun,” he has been hailed by The Beijing News as the “Steve Jobs of the biotechnology industry.” Cayudi is China’s first company to develop a point-of-care molecular diagnostics technology platform. Its products have been included in the World Health Organization’s recommended list and are deployed for rapid on-site molecular diagnostic testing at Terminals 2 and 3 of Beijing Capital International Airport, making Cayudi the first supplier of molecular diagnostic equipment in China.

He successively managed business operations in China and Greater China for multinational corporations including Johnson & Johnson Medical, Sanofi, Boston Scientific, and Medtronic. He established the strategic and developmental foundation for Medtronic’s diabetes business. In 2009, he joined MicroPort as Vice President, where he launched MicroPort’s diabetes division through its first merger and acquisition integration. He spearheaded the development and commercialization of China’s only pituitary hormone pump. In 2014, he founded Innoda Medical, focusing on the research and development of micro-drug infusion systems. As a co-founder and CEO, he established LenoMed Medical, creating a medical device incubation platform in partnership with Legend Capital. In the same year, he participated in the management of Kelite as a Director and CEO.

Master of Neurology from Capital Medical University, Ph.D. in Diagnostic Radiology; five years of experience as a neurologist and three years as a radiologist; independent iOS developer who has released six apps, including a leading normal brain MRI atlas that sold over 1,000 copies in the United States within one year of launch, generating more than $10,000 in revenue.

Professor at Soochow University, internationally renowned in the field of fully magnetically levitated artificial heart technology. Returned to China in 2008 to start a business, leading the research and development of the CH-VAD artificial heart, achieving breakthroughs in cutting-edge international technology.

Ph.D. Supervisor, Department of Electronic Engineering, Tsinghua University; Principal Investigator, California Institute of Technology; One of China’s Top Ten Emerging Sci-Tech Figures (2015); Scientist of the Year, Science China (2015). Dr. Bao Jie completed his undergraduate studies at Tsinghua University and earned his Ph.D. from Brown University, followed by postdoctoral research at the Massachusetts Institute of Technology.